FOXA3 and metabolic disease: Accordingly, Foxa3-null mice have increased BAT, enhanced browning, and thermogenic capacity upon aging, accompanied by a less expanded adipose tissue, decreased insulin resistance, and increased longevity, further supporting a role for Foxa3 in energy expenditure and in age-associated metabolic disorders [27].